1Riondion S, Pignatelli P, Pulcinelli FM, et al. Platelet hyperac tivity in hypertension older patients is controlled by lower blood pressure[J].J Am Geriatr Soc,1999,47:943-947.
2Verhaar MC, Beutler JJ, Gaillard CA, et al. Progressive vascular damage in hypertensive is associated with increased levels of circulating P-selectin[J].J Hypertens,1998,16:45-50.
3Lip GYH, Edmunds E, Hee FLLS, et al. A crosssectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension[J].Am J Hypertens,2001,14:823-828.
4Blann AD, Dobrotova M, Kubisz P, et al. Von willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis[J].Thromb Haemost,1995,74:626-630.
5Weiss SJ. Tissue destruction by neutrophils[J].N Engl J Med,1989,330:365-376.
6Minamino J, Kitakaze M, Asanuma H, et al. Plasma adenosine levels and platelet activation on patients with atrial fibrillation[J].Am J Cardiol,1999,83:194-198.
7Davi G, Romano M, Mezzetti A, et al. Increased levels of soluble P-selectin in hypercholesterolemic patients[J].Circulation,1998,97:953-957.
8Andreassen AK, Nord I, Simonsen S, et al. Levels of circulating adhension molecules in congestive heart failure and after heart transplantation[J].Am J Cardiol,1998,81:604-608.
9Connor CM, Guebel PA, Serebruanny VL. Usefulness of soluble and surface bound P-selectin in detecting heightened platelet activity in patients with congestive heart failure[J].Am J Cardiol,1999,83:1345-1349.
10Christopher R, Andrew D, Robert DS, et al. Abnormalities of hemorrheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm. Effects of angiotensin converting enzyme inhibitor and β-blocker therapy[J].Circulation,2001,103:1746-1751.
